TERM ID="NYU_TERM_1" STRING="P-HPT" FREQUENCY=3 START=485 END=490 LEMMA="PRIMARY HYPERPARATHYROIDISM" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_2" STRING="P-HPT" FREQUENCY=3 START=568 END=573 LEMMA="PRIMARY HYPERPARATHYROIDISM" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_3" STRING="P-HPT" FREQUENCY=3 START=900 END=905 LEMMA="PRIMARY HYPERPARATHYROIDISM" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_4" STRING="P-HPT patients" FREQUENCY=1 START=1015 END=1029 LEMMA="P-HPT PATIENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_5" STRING="PTH levels" FREQUENCY=1 START=637 END=647 LEMMA="PTH LEVEL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_6" STRING="adenomas" FREQUENCY=1 START=656 END=664 LEMMA="ADENOMA" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_7" STRING="essential actions" FREQUENCY=1 START=84 END=101 LEMMA="ESSENTIAL ACTION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_8" STRING="including osteitis fibrosa cystica" FREQUENCY=1 START=695 END=729 LEMMA="INCLUDING OSTEITIS FIBROSA CYSTICA" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_9" STRING="inhibiting PTH secretion" FREQUENCY=1 START=124 END=148 LEMMA="INHIBITING PTH SECRETION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_10" STRING="negative post-operative outcomes" FREQUENCY=1 START=742 END=774 LEMMA="NEGATIVE POST-OPERATIVE OUTCOME" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_11" STRING="ng/ml" FREQUENCY=1 START=948 END=953 LEMMA="NG/ML" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_12" STRING="parathyroid cell proliferation" FREQUENCY=1 START=154 END=184 LEMMA="PARATHYROID CELL PROLIFERATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_13" STRING="parathyroid cells" FREQUENCY=1 START=105 END=122 LEMMA="PARATHYROID CELL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_14" STRING="parathyroid hyperplasia" FREQUENCY=1 START=327 END=350 LEMMA="PARATHYROID HYPERPLASIA" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_15" STRING="parathyroidectomy" FREQUENCY=1 START=785 END=802 LEMMA="PARATHYROIDECTOMY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_16" STRING="pathogenesis" FREQUENCY=1 START=234 END=246 LEMMA="PATHOGENESI" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_17" STRING="pathogenesis of secondary hyperparathyroidism" FREQUENCY=1 START=234 END=279 LEMMA="SECONDARY HYPERPARATHYROIDISM PATHOGENESI" LEMMA_FREQUENCY=1 HEAD_TERM="pathogenesis" HEAD_LEMMA="PATHOGENESI"
TERM ID="NYU_TERM_18" STRING="phenotype" FREQUENCY=1 START=684 END=693 LEMMA="PHENOTYPE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_19" STRING="primary hyperparathyroidism" FREQUENCY=2 START=456 END=483 LEMMA="PRIMARY HYPERPARATHYROIDISM" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_20" STRING="primary hyperparathyroidism" FREQUENCY=2 START=456 END=483 LEMMA="PRIMARY HYPERPARATHYROIDISM" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_21" STRING="primary hyperparathyroidism Vitamin D" FREQUENCY=1 START=25 END=62 LEMMA="PRIMARY HYPERPARATHYROIDISM VITAMIN D" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_22" STRING="receptor" FREQUENCY=1 START=71 END=79 LEMMA="RECEPTOR" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_23" STRING="renal insufficiency" FREQUENCY=1 START=368 END=387 LEMMA="RENAL INSUFFICIENCY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_24" STRING="risk/benefit profile" FREQUENCY=1 START=1094 END=1114 LEMMA="RISK/BENEFIT PROFILE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_25" STRING="secondary hyperparathyroidism" FREQUENCY=1 START=250 END=279 LEMMA="SECONDARY HYPERPARATHYROIDISM" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_26" STRING="supplementation" FREQUENCY=1 START=996 END=1011 LEMMA="SUPPLEMENTATION" LEMMA_FREQUENCY=1
